Bristol-Myers Squibb Co. (BMY) PT Raised to $65 at Goldman Sachs, Positively Revises EPS Estimates
Tweet Send to a Friend
Goldman Sachs raised its price target on Bristol-Myers Squibb Co. (NYSE: BMY) to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
